A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

July 14, 2008

Blood Tests Could Replace Liver Biopsies for Hep C

A series of blood tests was nearly as accurate at predicting the progression of liver damage as liver biopsies in people coinfected with both HIV and hepatitis C virus (HCV), say the authors of a study published in the July 31 issue of AIDS. The high level of accuracy, the authors conclude, may reduce the number of liver biopsies in coinfected patients by 83 percent.

Currently, the gold standard for assessing the progression of liver damage, or fibrosis, caused by HCV infection is a liver biopsy. Unfortunately, biopsies are expensive, can be quite painful and carry the risk of internal bleeding.

To investigate whether a series of blood tests, or markers, may be as accurate as a biopsy, Daniel Suzman, MD, and his colleagues from the National Institutes of Health (NIH) in Bethesda, Maryland, studied 100 blood and biopsy samples from 68 people coinfected with HIV and HCV. Suzman’s team found that an eight-marker system—six blood tests combined with a person’s age and whether or not he or she has used antiretroviral (ARV) HIV therapy—correctly classified the stage of liver damage 88 percent of the time.

Suzman’s team also found that a four-marker system—all blood tests—was statistically equivalent to the eight-marker system. The authors caution, however, that their systems will need to be validated in larger clinical trials before being viewed as a replacement for liver biopsies.

Search: hepatitis C, HCV, liver biopsy, biopsies, Daniel Suzman, National Institutes of Health, NIH


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Charles J Etheridge, Atlanta, 2008-07-16 15:27:55
As one who is coinfected I thought that this was very intresting. As it happens I have an appointment at the Atlanta VA on Friday to be seen by the Advanced Liver Disease Clinic and will print this and take it in with me. I am interested in being treated with VX-950 as soon as it is out of the trials, so I hope that is very soon. For the record I have been infected with HIV for nearly 30 years, but at this time one Atripla per day is keeping me undetectable.

comments 1 - 1 (of 1 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    j_powell01
    Bakersfield
    California


    zachowell86
    Birmingham
    Alabama


    Tuffie
    Washington DC
    DC


    Dreaming
    Montgomery County
    Maryland
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.